Meningioangiomatosis is associated with neurofibromatosis 2 but not with somatic alterations of the NF2 gene

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 5, 1997, Pages 485-489

  Stemmer Rachamimov, Anat O ^a   Horgan, Michael A ^a,b   Taratuto, Ana Lia ^c   Munoz, David G ^d   Smith, Thomas W ^e   Frosch, Matthew P ^f   Louis, David N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Meningioangiomatosis; Neurofibromatosis 2; NF2 gene

Indexed keywords

DNA;

ARTICLE; BRAIN HEMANGIOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GERM LINE; HUMAN; HUMAN TISSUE; MENINGIOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0030734712     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199705000-00004     Document Type: Article

References (43)

1. Bassoe P, Nuzum F. Report of a case of central and peripheral neurofibromatosis. J Nerv Ment Dis 1915;42:785-96
2. Worster-Drought C, Carnegie Dickson WE, McMenemey WH. Multiple meningeal and perineural tumours with analogous changes in the glia and ependyma (neurofibroblastomatosis). Brain 1937;60: 85-117
3. Kollias SS, Crone KR, Ball WS, Prenger EC, Ballard ET. Meningioangiomatosis of the brain stem. J Neurosurg 1994;80:732-35
4. Halper J, Scheithauer BW, Okazaki H, Laws ER. Meningioangiomatosis: A report of six cases with special reference to the occurrence of neurofibrillary tangles. J Neuropath Exp Neurol 1986;45:426-46
5. Paulus W, Peiffer J, Roggendorf W, Schuppan D. Meningioangiomatosis. Path Res Pract 1989;184:446-52
6. Ogilvy CS, Chapman PH, Gray M, de la Monte SM. Meningioangiomatosis in a patient without von Recklinghausen's disease. J Neurosurg 1989;70:483-85
7. Kasantikul V, Brown WJ. Meningioangiomatosis in the absence of von Recklinghausen's disease. Surg Neurol 1980;15:71-75
8. Prayson RA. Meningioangiomatosis: A clinicopathologic study including MIB1 immunoreactivity. Arch Pathol Lab Med 1995;119: 1061-64
9. Kunishio K, Yamamoto Y, Sunami N, et al. Histopathologic investigation of a case of meningioangiomatosis not associated with von Recklinghausen's disease. Surg Neurol 1987;27:575-79
10. Sakaki S, Nakagawa K, Nakamura K, Takeda S. Meningioangiomatosis not associated with von Recklinghausen's disease. Neurosurgery 1987;20:797-801
11. Liu SS, Johnson PC, Sonntag VKH. Meningioangiomatosis: A case report. Surg Neurol 1989;31:376-80
12. Louis DN, Ramesh V, Gusella JF. Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol 1995;5:163-72
13. Gusella J, Ramesh V, MacCollin M, Jacoby L. NF2: Loss of merlin's protective spell. Curr Opp Genet Develop 1996;6:87-92
14. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 1993;363:515-21
15. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72:791-800
16. Wellenreuther R, Kraus JA, Lenartz D, et al. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 1995;146:827-32
17. Ruttledge MH, Sarrazin J, Rangaratnam S, et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nature Genet 1994;6:180-84
18. Jacoby LB, MacCollin M, Louis DN, et al. Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 1994;3: 413-19
19. Evans DGR, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Quart J Med 1992;304:603-18
20. Huson SM, Harper PS, Compston DAS. von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 1988;111:1355-81
21. Short MP, Martuza RL, Huson SM. Neurofibromatosis 2: Clinical features, genetic counselling, and management issues. In: Huson SM, C. HRA, eds. The neurofibromatoses: A pathogenetic and clinical overview. London: Chapman & Hall Medical, 1994:414-44
22. Lubienecki E, Pomata H, Gallo G, Diaz D, Seviever G, Taratuto AL. Meningioangiomatosis: An immunocytocheical study. J Neuropathol Exp Neurol 1995;54:467
23. Ono Y, Tamiya T, Ichikawa T, et al. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices. J Neuropathol Exp Neurol 1996;55:1026-31
24. Louis DN, von Deimling A, Seizinger BR. A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small, and archival human brain tumor specimens. Am J Pathol 1992;141: 777-82
25. Joseph JT, Lisle DK, Jacoby LB, et al. The NF2 gene analysis distinguishes hemangiopericytoma from meningioma. Am J Pathol 1995;147:1450-55
26. MacCollin M, Ramesh V, Jacoby LB, et al. Mutational analysis of patients with neurofibromatosis 2. 1994;55:314-20
27. Beck E. Ein beitrag zur kenntnis der neurofibromatose (Recklinghausensche krankheit). Ztschr f d Ges Neurol u Psychiat 1938;164: 748-89
28. Beck E. Zwei falle von neurofibromatose mit befallensein des zentralnervensystems. Ztschr f d Ges Neurol u Psychiat 1939;164:748-89
29. Foerster O, Gagel O. Ein fall von Recklinghausenscher krankheit mit funf nebeneinander bestehenden verschiedenartigen tumorbildungen. Ztch f d Ges Neurol u Psychiat 1932;138:339-60
30. Feigin I. The nerve sheath tumor, solitary and in von Recklinghausen's disease; a unitary mesenchymal concept. Acta neuropath (Berl) 1971;17:188-200
31. Hozay J. Une angioneuromatose meningo-encephalique diffuse. Revue Neurologique 1953;89:222-36
32. Rubinstein LJ. The malformative central nervous system lesions in the central and peripheral forms of neurofibromatosis. A neuropathological study of 22 cases. Ann NY Acad Sci 1986;486:14-29
33. Russell DS, Rubinstein LJ. Pathology of tumours of the nervous system. Baltimore: Williams & Wilkins, 1989
34. Rubinstein LJ. Tumors of the central nervous system. Washington, DC: Armed Forces Institute of Pathology, 1972
35. Blumenthal D, Berho M, Bloomfield S, Schochet SS, Kaufman HH. Childhood meningioma associated with meningioangiomatosis. J Neurosurg 1993;78:287-89
36. Harada K, Inagawa T, Nagasako R. A case of meningioangiomatosis without von Recklinghausen's disease. Report of a case and review of 13 cases. Child's Nerv Syst 1994;10:126-30
37. Aizpuru RN, Quencer RM, Norenberg M, Altman N, Smirniotopoulos J. Meningioangiomatosis: Clinical, radiologie and histopathologic correlation. Radiology 1991;179:819-21
38. Partington CR, Graves VB, Hegstrand LR. Meningioangiomatosis. AJNR 1990;12:549-52
39. Dianzani I, Camaschella C, Ponzone A, Cotton RGH. Dilemmas and progress in mutation detection. Trends Genet 1993;9:403-5
40. Hayashi K. PCR-SSCP: A simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Applic 1991;1:34-38
41. Knudson AG. All in the (cancer) family. Nature Genet 1993;5:103-4
42. Varanasi R, Bardeesy N, Ghahremani M, et al. Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proc Natl Acad Sci USA 1994;91:3554-58
43. Boyd J. BRCA1: More than a hereditary breast cancer gene? Nature Genet 1995;9:335-36